Verrica Pharmaceuticals Inc. (VRCA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 88.52M |
| Enterprise Value | 60.01M |
| P/E Ratio | -2.77 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 2.73 |
| Price/Book Ratio | 23.84 |
| Enterprise/Revenue | 2.42 |
| Enterprise/EBITDA | -2.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -1.03 |
| Operating Margin | -0.93 |
| Return On Assets | -0.87 |
| Return On Equity | -4.44 |
| Revenue | 35.58M |
| Revenue/Share | 1.42 |
| Gross Profit | 32.14M |
| EBITDA | -9.36M |
| Net Income | -17.89M |
| Diluted EPS | -1.68 |
| Total Cash | 11.2M |
| Total Cash/Share | 0.53 |
| Total Debt | 1.81M |
| Total Debt/Equity | 0.42 |
| Current Ratio | 1.45 |
| Book Value Per Share | 0.2 |
| 52-Week Change | -19.53 |
| 52-Week High | 9.82 |
| 52-Week Low | 3.28 |
| Moving Average 50 Days | 5.6 |
| Moving Average 200 Days | 6.18 |
| Average Volume | 46,320 |
| Shares Outstanding | 17.18M |
| % Held by Institutions | 44.85 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 25, 2025 |